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Abstract: To protect themselves, plants accumulate an armoury of antimicrobial secondary 
metabolites. Some metabolites represent constitutive chemical barriers to microbial attack 
(phytoanticipins) and others inducible antimicrobials (phytoalexins). They are extensively 
studied as promising plant and human disease-controlling agents. This review discusses the 
bioactivity of several phytoalexins and phytoanticipins defending plants against fungal and 
bacterial aggressors and those with antibacterial activities against pathogens affecting 
humans such as Pseudomonas aeruginosa and Staphylococcus aureus involved in 
respiratory infections of cystic fibrosis patients. The utility of plant products as “antibiotic 
potentiators” and “virulence attenuators” is also described as well as some biotechnological 
applications in phytoprotection. 
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1. Introduction 
 
Plants are continuously in contact with different microorganisms, including viruses, bacteria and 
fungi. The relationships established with some of them are beneficial for the plants; thus, some 
bacteria known as rhizobia, form symbiotic association with leguminous plants by fixing atmospheric 
nitrogen in root nodules. Other bacteria found close to the plant root (rhizobacteria) are able to control 
plant diseases caused by soil pathogens [1]. Fungal interactions can also be positive for the plant, 
stimulating its growth and development as in the case of mycorrhizae [2]. But many plant-associated 
microbes are pathogens that affect plant development, reproduction and ultimately yield production. 
The control of these pathogens is a major challenge in agriculture. 
To arrest the spread of pathogens, plants possess an innate immunity that involves different layers 
of defence responses. Some of these defences are preformed and others are activated after recognition 
of pathogen elicitors [3], and include reinforcement of the cell wall, biosynthesis of lytic enzymes and 
production of secondary metabolites and pathogenesis related proteins [4]. In this review, we will 
focus on the description of the secondary metabolites, both preformed and pathogen-induced, that the 
plant accumulates in response to pathogen invasion, with special emphasis on their biological role 
against microorganisms and their biotechnological values as potential antimicrobials in plant 
protection and human health. 
 
2. Phytoanticipins versus Phytoalexins 
 
The antimicrobial plant compounds that have received more attention in plant defence are the 
phytoalexins (Figure 1). Phytoalexins are antimicrobial compounds which require de novo expression 
of the enzymes involved in their biosynthetic pathways after elicitation [2]. Therefore, the production 
of phytoalexins requires transcriptional and/or translational activity in the plant once the pathogen has 
been detected. The induced response mechanism also involves the trafficking and secretion of 
antimicrobial compounds to the infection site [5]. This definition of phytoalexins differs from the 
original one by Müller and Börger [6] and avoids the assignation of a role in disease resistance for 
these molecules, because, although a function in plant defence is assumed for these compounds, such a 
role cannot always be easily proven.  
Similarly, the term phytoanticipin was coined by vanEtten et al. [7] referring to “low molecular 
weight antimicrobial compounds that are present in plants before challenge by microorganisms or are 
produced after infection solely from preexisting constituents” (Figure 2). Some phytoanticipins are 
found at the plant surface. Others are sequestered as preformed compounds in vacuoles or organelles 
and released through a hydrolyzing enzyme after pathogen challenge. Because the enzyme involved in 
the final liberation of the molecule is not formed de novo these compounds are not considered as 
phytoalexins [8]. 
The previous definitions are based on the dynamic of the synthesis of the antimicrobial molecule, 
not on its chemical composition, which can be confusing sometimes since the same chemical can be a 
phytoalexins in one plant and a phytoanticipin in another and moreover, the same molecule can be a 
phytoalexin or a phytoanticipin in different organs of the same plant [2]. 
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Figure 1. Examples of antimicrobial phytoalexin structures. (A) Scopoletin from tobacco, 
(B) camalexin from A. Thaliana, (C) sakuranetin, (D) nomilactone B from rice, and (E) 
glucosinolates from Brassicacea. Structures of the R groups of indol-3-ylmethyl (E, left) 
and 4-methylsulfinylbutyl glucosinolate (E, right) are shown as examples of Arabidopsis 
tryptophan- and methionine-derived glucosinolates, respectively. 
 
 
Figure 2. Examples of antimicrobial phytoanticipin structures. (A) The major oat root 
saponin avenacin A-1, and (B) the saponin α-tomatine from tomato. Tomatidine is the 
aglycon version of the phytoanticipin tomatine. 
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Several pieces of evidence indicate that preformed and induced antimicrobial chemicals confer 
protection against disease. We will focus next on the description of examples of phytoanticipins and 
phytoalexins for which the biological roles in plant defence responses have been characterized. 
 
2.1. Phytoanticipins involved in defence responses 
 
In this section, we describe the role of saponins in plant disease resistance. Saponins are 
glycosylated phytoanticipins that are found in a wide range of plant species and can be divided into 
three major groups, triterpenoid, steroid or steroidal glycoalkaloid, depending on the structure of their 
aglycones [8]. Because they have potent antimicrobial activities it is proposed that the natural role of 
these molecules in plants is to confer protection against potential pathogens [9]. The saponins studied 
in deepest detail in relation to their potential role in defence are avenacin and α-tomatine. Avenacins 
are oat root saponins. The antifugal activity of avenacin is associated with its ability to form 
complexes with sterols present in fungal membrane leading to pore formation and loss of membrane 
integrity [10]. The localization of the major avenacin, avenacin A-1, in the epidermal cell layer of oat 
root tips and in the emerging lateral root initials, suggests a role as a chemical barrier [11]. Moreover, 
the capacity of Gaeumannomyces graminis var avenae to detoxify avenacin A-1 has been shown to be 
essential for its interaction with oat. Fungal mutants lacking the saponin-detoxifying enzyme 
avenacinase showed increased sensitivity to avenacin A-1 and were no longer able to infect [12]. 
Saponin-deficient mutants also showed compromised resistance to several pathogens, indicating that 
avenacins provide a preformed chemical defence to pathogen attack [13]. Interestingly, accumulation 
of avenacin biosynthesis pathway intermediates in oat roots results in callose accumulation, a well 
known defence mechanism which suggests that phytoanticipin accumulation may also trigger other 
defence responses [14]. This implies that the antimicrobials may work in defence-related signalling 
processes and strengthen the relevance of these compounds as biotechnological weapons against 
pathogen infection [5]. 
The major saponin in tomato is α-tomatine. This phytoanticipin is accumulated in healthy plants in 
its biologically active form. Relationship between α-tomatine accumulation and disease resistance has 
been difficult to show in tomato, since the tested fungi showed some degree of resistance to the 
compound by producing tomatine-detoxifying enzymes [8]. Actually, for some phytopathogenic fungi, 
the production of α-tomatine-detoxifying enzymes is a determinant of virulence against α-tomatine-
containing host, providing an evidence of the role of this compound in plant defence. Thus, Septoria 
lycopersici produces tomatinase, an extracellular enzyme that hydrolyses α-tomatine to β2-tomatine, 
which is less toxic to the fungus. Infection with a tomatinase-deficient strain of S. lycopersici enhanced 
defence responses in tomato [15] and the mutant strain was unable to infect the normally susceptible 
host Nicotiana benthamiana [16]. More interestingly, the degradation product of α-tomatine is able to 
suppress the defence response. Thus, inoculation of N. benthamiana with α-tomatine or β2-tomatine 
before infection with the tomatinase-deficient mutant of S. lycopersici allows the mutant pathogen to 
infect the host in the case of β2-tomatine but not α-tomatine. Moreover, pretreatment with β2-tomatine 
increases the resistance to Pseudomonas syringae pv tabaci conferred by the gene Pto  (from 
Pseudomonas tomato resistance gene) [16]. Similarly, Fusarium oxysporum f. sp lycopersici is able to 
degrade  α-tomatine into tomatidine and lycotetraose, compounds that inhibit the hypersensitive Int. J. Mol. Sci. 2009, 10                 
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response induced cell death in tomato [17]. Therefore in the previous examples, pathogen resistance 
cannot only be attributed to the disappearance of the antimicrobial compound, but also to the capacity 
of the degradation product of the phytoanticipins to suppress defence responses. In this case it is 
difficult to elucidate the role of the phytoanticipins themselves in pathogen resistance, since the fungus 
has evolved a sophisticated way to overcome defence responses by taking advantage of the 
degradation product of these molecules [17]. 
 
2.2. Phytoalexins: Some biological examples 
 
In this section we discuss the role of the tobacco phytoalexin scopoletin, the phytoalexins in   
the defence response of rice and crucifers and the biological function of phytoalexins found in the  
root exudate. 
The hydroxycoumarin scopoletin (6-methoxy-7-hydroxycoumarin) is the major phytoalexin in 
tobacco plants. This compound is well known to display antimicrobial properties in vitro [18] and 
accumulates in tobacco reacting to pathogens and elicitors [19,20]. It is responsible for the appearance 
of a remarkably bright blue fluorescence under UV light in the tissues surrounding necrotic lesions 
[21] and it has been proposed to act as a scavenger of reactive oxygen species produced in excess after 
triggering of the hypersensitive response [22]. Interestingly, the reduction of scopoletin and the 
glucoside form of scopoletin (scopolin) levels in tobacco plants has been associated with a decrease of 
resistance to infection with TMV [19] providing an evidence of the antimicrobial role of this 
compound in planta. 
Rice is among the most economically important world crops. One of the most serious diseases 
affecting rice is the rice blast produced by Pyricularia oryzae, which can cause important yield losses. 
One approach to improve rice resistance to blast could be the culture of rice genotypes producing anti- 
P. oryzae phytoalexins [2]. Therefore, the analysis of the correlation between rice blast infection and 
production of host phytoalexins has been an important area of research in the past. There are a wide 
variety of secondary metabolites produced in rice after elicitation of the host response for which 
antifungal activity has been shown. Among them sakuranetin and momilactone A have attracted 
special interests [2]. Sakuranetin is a powerful antifungal derived from the flavonoid naringenin [23] 
while momilactone A is a diterpenoid [24]. For both of them, an accumulation of the molecule in the 
disease lesion of rice – P. oryzae incompatible interaction (Tetep rice cultivar which is resistant to P 
oryzae) has been shown [25]. Moreover, a correlation between the rice genotypes that accumulate 
higher concentrations of these phytoalexins and the degree of resistance to P. oryzae was established 
[25]. Nevertheless in these experiments the induction of each of the phytoalexin synthesis was done 
through exposure to UV light and interpretations from the results have to be taken carefully since 
differences can be observed between the production of phytoalexins after UV exposure and P. oryzae 
infection. More recently a work showing that enhancing of the momilactone accumulation in rice after 
silicon treatment increased rice resistance to blast has been published [26]. In sum, these results 
indicate that phytoalexins can be a determinant molecular weapon against blast pathogen infection  
in rice. 
The plant family Brassicaceae (crucifers) includes a large number of economically important crops 
and their members are known to synthesize a vast variety of secondary metabolites involved not only Int. J. Mol. Sci. 2009, 10                 
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in defence against microorganisms, but also in human health. Most of the phytoalexins of this family 
are derived from tryptophan, and they have been involved in protection against biotic and abiotic 
stresses [27]. Several phytoalexins of the crucifers have been shown to have growth inhibitory 
activities against fungal pathogens [28], but attempts to show a role of these molecules as pathogen 
inhibitors in planta have been mostly unsuccessful due to the ability of the tested fungi to metabolize 
the phytoalexins. 
Recent studies show that glucosinolates, thioglucosides constitutively stored in crucifers, are also 
involved in the response to pathogens [29,30]. Glucosinolates and their degradation products have 
been traditionally considered anti-insect compounds but they also have been proposed as 
antimicrobials [5]. Recently a metabolic pathway of glucosinolates that differs from the pathway 
activated by chewing-insect was identified. This new pathway is involved in antifungal defence 
responses and involves the biosynthesis of the compound 4-methoxyindol-3-ylmethylglucosinolate   
(4-methoxy-I3G) and subsequent activation by a myrosinase [29]. More interestingly, both the 
synthesis and the degradation of 4-methoxy-I3G are mandatory for the accumulation of callose after 
pathogen attack and ultimately resistance to several microbial pathogens [30]. These results suggest 
that 4-methoxy-I3G degradation products are either cofactors or elicitors of callose deposition, and 
suggest an additional role for the phytoalexin besides antimicrobial activity [5]. 
The best studied phytoalexin is camalexin, from the model plant Arabidopsis thaliana. Camalexin 
refers to the molecule 3-thiazol-2’-yl-indole which was isolated from the leaves of the crucifer 
Camelina sativa infected with Alternaria brassicae [31]. This phytoalexin has been found in other 
members of the crucifers, but we will refer here only to studies in Arabidopsis, since it provides an 
exceptional model for the investigation of phytoalexins in defence responses. 
Camalexin production is induced in Arabidopsis after infection with bacteria, viruses, fungi and 
oomycetes. As most of the phytoalexins from crucifers, it is synthesized from tryptophan. The first 
step is the synthesis of indole-3-acetaldoxime (IAOx) catalyzed by CYP79B2 and CYP79B3. The 
IAOx-metabolizing steps are not well known until the last step of the pathway in which 
dihydrocamalexic acid is decarboxylated to camalexin [31]. High concentrations of camalexin have 
been observed at the infection site of Alternaria alternata [32] and in the proximity to the lesions 
induced by Botrytis [33], and this distribution correlates with a high induction of tryptophan and 
camalexin biosynthetic genes [32,34]. We previously mentioned that camalexin production is induced 
by a high number of pathogen, but a growth inhibition effect of the phytoalexins has been shown only 
for some of them [31]. Several attempts to correlate in vitro antimicrobial activity and plant resistance 
to infection have been done. An advantage in the use of Arabidopsis is the availability of a high 
number of mutants that allow studying the role of camalexin in the defence response. The mutant pad3 
is unable to metabolize the last step in the synthesis of camalexin, and therefore the molecule is not 
accumulated in this mutant. The pad3 mutant did not show an increased sensitivity to infection by 
Pseudomona syringae pv maculicula in respect to the control. Moreover, camalexin was shown only to 
disrupt the integrity of bacterial membranes at a concentration that is probably much higher than the 
one reached in planta and this further suggests that this compound is not necessary to stop the bacterial 
infection [35]. On the other hand, pad3  mutants show enhanced susceptibility to Alternaria 
brassicicola and Leptosphaeria maculans [35,36], which agrees with a 10-fold lower concentration of 
the phytoalexin needed to inhibit susceptible fungi compare to Gram negative bacteria [35]. Int. J. Mol. Sci. 2009, 10                 
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Other works that have not used mutant hosts also suggest a role for camalexin in defence responses. 
Thus, wounding of Arabidopsis leaves have been shown to increase the resistance to B. cinerea in a 
camalexin-dependent way, suggesting a determinant role for this compound in Arabidopsis resistance 
against B. cinerea [37]. On the other hand, studies on the virulence of pathogen isolates with different 
susceptibilities to camalexin have also been carried out for Botrytis cinerea [33]. Kliebenstein et al., 
showed that the degree of tolerance of B. cinerea isolates to camalexin determines the ability of the 
isolate to infect the wild-type plant, while they can all infect a camalexin-deficient mutant. Therefore, 
camalexin contribution to the host defence response is limited to the phytoalexin-susceptible isolates. 
Interestingly, the camalexin-susceptible pathogens induce much higher accumulation of camalexin 
than camalexin-tolerant ones. The results show that camalexin is an important defence response in 
Arabidopsis against B. cinerea and suggest that some B. cinerea isolates are able to overcome this 
response by an unknown mechanism. For instance, the induction of an ABC transporter that supports 
efflux of fungitoxic compounds after camalexin exposure was reported for B. cinerea. Accordingly, a 
strain lacking the functional transporter is more susceptible to camalexin in vitro and less virulent on 
wild-type plants, but is still fully virulent on camalexin-deficient mutants [38]. This work describes a 
virulence factor in B. cinerea that allows the pathogen to overcome a plant defence mechanism and 
strengthen the argument about camalexin being a determinant defence against B. cinerea. 
Several examples of fungi metabolizing camalexin have been also reported and include virulent 
isolates of Rhizoctonia solani, that degrades camalexin through 5’-hydroxylation of the indole ring or 
through the formation of an oxazoline derivate [39] and the stem rot phytopathogen Sclerotinia 
sclerotiorum which is able to transform camalexin into the glycosylated derivate at N-1 or C-6 of the 
indole ring [40]. 
Despite the importance of the root as a plant organ in continuous contact with the rhizosphere 
pathogens, there is not much information about the antimicrobial compounds that integrate the root 
exudates. A few reports describe the exudation of secondary metabolites after elicitation of the root 
with fungal pathogens, and for some of these metabolites antimicrobial activities against a wide range 
of microorganisms have been shown (reviewed in [1]). A detailed analysis of root exudates in 
Arabidopsis challenged with Pseudomonas syringae provides a strong argument for the role of 
antimicrobial compounds from the root exudates in the plant defence mechanism to this bacterium 
[41]. Bais et al. showed that seven out of eight strains of P. syringae are unable to infect Arabidopsis 
and they describe how non-pathogenic strains induce the exudation of more secondary metabolites 
than non-infected plants or the plants infected with a virulent strain. The bacteriostatic activity of the 
root exudates elicited by non-pathogenic bacteria was measured and found to be moderate against the 
seven non-infecting strains. Accordingly, the root exudates elicited by the infecting strain had no 
significant bacteriostatic activity against any of the P. syringae strain. More interestingly the authors 
identify the possible mechanism of resistance of the infecting strain to the antimicrobial compounds, 
and they proposed that this strain is able to both block the exudation and partially resists to the 
antibiotic through its type III secretion system. This work provides an excellent example of the 
determinant role of some phytoalexins and phytoanticipins in arresting pathogen growth and how some 
pathogens have evolved to overcome this defence mechanism. 
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3. Use of Phytoanticipins and Phytoalexins as Antibacterial Agents in Human Medicine 
 
Two major circumstances have accentuated research aiming at the discovery of antibacterial agents 
derived from plant natural products in the last decade. First, nosocomial and community-acquired 
infections caused by bacteria that are resistant to more than two classes of conventional antibiotics 
represent an increasingly important public health concern. A reason for the problem of multidrug 
resistance (MDR) resides on the fact that the current arsenal of antibiotics has been largely designed on 
limited chemical scaffolds with only few innovations since the 1980s, leaving an opportunity for 
pathogens to develop and spread antibiotic resistance mechanisms worldwide [42,43]. Second, the 
high popularity and general acceptance of natural products as tools for disease prevention and health 
maintenance have made discovery efforts for specific bioactive components from plant extracts surge 
[44,45], and there are now numerous reports of plant products providing antibiotic activities against a 
wide variety of pathogenic bacteria. Multiple classes of antibacterial products, including phenolic acids 
and polyphenols [46], phenanthrenes [47], flavonoids [48], terpenoids [49] have been described and 
the bioactivities of many more plant products and essential oils are reviewed elsewhere [44,50,51]. 
Interestingly, at this time, no product has been approved for systemic use to combat bacterial 
infections, in part because the spectrum of activity or the mode of action of purified components is 
often very narrow or non specific, respectively. It also has been difficult to isolate specific active 
components from plant extracts consisting of a mixture of a large number of structurally related 
compounds with varying degrees of bioactivity or even opposing effects (growth inhibitors vs growth 
stimulants) and even some with cytotoxicity [52]. Most of the bacterial plant pathogens are Gram 
negative and most of the biologically active purified plant products show low activity against such 
organisms. Gram positive bacteria are often nevertheless susceptible to plant products and this 
suggests that the fundamental morphological differences in the cell wall and membrane organization of 
Gram negative and Gram positive organisms modulate their susceptibility to purified phytoanticipins 
and phytoalexins. This also suggests that the combine effects of the mixture of natural compounds 
found in planta might be necessary to obtain a synergistic antibacterial activity against Gram negative 
organisms. Of course, several successful plant pathogens are nevertheless able to circumvent the toxic 
effects of these plant metabolites. 
Thanks to the persisting efforts of the scientific community, advances in the understanding of the 
mode of action of bioactive plant products and in the experimental approaches needed to evidence the 
bioactivities of various plant extracts and individual compounds have allowed identification of 
interesting leads that enhance the probability of some therapeutic applications. The following 
discussion provides some original examples of how natural plant products can contribute to enhance 
the weaponry needed to tackle pathogenic bacteria affecting humans. Currently, two potential 
applications of phytoanticipins or phytoalexins seem adequate for therapeutic use. Some plant products 
defined as “antibiotic potentiators” could allow the current conventional arsenal of antibiotics to gain 
back some of the therapeutic applications lost from the spread of MDR, and others, defined as 
“virulence attenuators” could assist the host immune system to adequately respond to the pathogen 
invasion (Figure 3). 
Several subtypes of plant products can be considered antibiotic potentiators. The most interesting 
family, i.e., bacterial efflux pump inhibitors, has met with convincing success in demonstrating marked Int. J. Mol. Sci. 2009, 10                 
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synergy when used in combination with conventional antibiotics against a variety of both Gram 
positive and Gram negative organisms. The MDR pumps are indeed among the major contributors in 
the intrinsic resistance of bacteria against a variety of toxic molecules such as alkaloid amphipathic 
cations, corresponding to many types of secondary metabolites found and produced in plants [53-56]. 
 
Figure 3. Some examples of plant products defined as “antibiotic potentiators” (A) or 
“virulence attenuators” (B) could allow the current conventional arsenal of antibiotics to 
gain back some of the therapeutic applications lost from the spread of MDR and others 
could assist the host immune system to adequately respond to the pathogen invasion.   
5’-MHC, 5’-methoxyhydnocarpin. 
 Int. J. Mol. Sci. 2009, 10                 
 
 
3409
Among putative efflux pump inhibitors, a catechin (epigallocatechin-gallate) found in green tea 
extracts abolished tetracycline resistance in staphylococcal isolates expressing TetK, one of the efflux 
pumps primarily found in Gram positive bacteria [57]. The mode of action of the catechin was 
attributed to the inhibition of the efflux pump by measuring the relative amount of tetracycline 
extruded from bacteria in the presence or absence of the catechin. Interaction with efflux pumps was 
further supported by the lack of minocycline potentiation in the presence of catechin since this 
semisynthetic tetracycline is known not to be a substrate for efflux pumps. Interestingly however, 
epigallocatechin-gallate was also found to potentiate the activity of β-lactam antibiotics against 
methicillin-resistant  Staphylococcus aureus (MRSA) by a mechanism other than efflux pump 
inhibition indicating the possible existence of a second mode of action [58]. Experiments from Zhao et 
al. [58] demonstrated binding of the catechin to the bacterial cell wall and hypersensitization of S. 
aureus to high ionic strength and low osmotic pressure. Similarly baicalein, a 5,6,7-trihydroflavone 
found in thyme extracts, also potentiates the antibacterial activity of tetracyclines and β-lactams 
against MRSA [59]. The inhibition of efflux pumps was demonstrated by blocking uptake of 
[
3H]tetracycline in inverted bacterial membrane vesicles prepared from TetK
+ E. coli. 
Interestingly, it exist at least one example of a mixture of an efflux pump inhibitor and a 
bactericidal compound naturally combined in planta. The medicinal plants Berberis were shown to 
produce both the antibacterial alkaloid berberine as well as the NorA efflux pump inhibitor   
5’-methoxyhydnocarpin [60]. The single-component NorA pump of S. aureus is a chromosomally-
encoded multidrug proton-dependent efflux transporter that is a member of the widespread major 
facilitator superfamily [53]. Against S. aureus, the NorA pump inhibitor had no antibacterial activity 
of its own but substantially potentiated the activity of NorA cationic substrates such as berberine and 
some fluoroquinolones. The action of 5’-methoxyhydnocarpin on NorA was identified by the 
inhibition of release of fluorescent berberine or ethidium bromide (another NorA substrate) from drug-
preloaded  S. aureus cells. Inversely, screening for efflux pump inhibitors in plant extracts using 
bioassays designed to detect synergy with conventional drugs led to the isolation of N-trans-feruloyl 
4’-O-methyldopamine from the methanolic extract of Mirabilis jalapa. This molecule was able to 
block NorA and thus significantly improve the activity of norfloxacin against S. aureus [61]. Bacterial 
pump inhibitors discovered from plant sources have recently been reviewed [62,63]. 
The observed synergy between berberine and 5’-methoxyhydnocarpin and the elucidation of its 
mode of action toward NorA has triggered the development of screens for identification of plant 
products that have antibiotic activities against Gram negative bacteria. In an example of such a screen, 
the utilization of known synthetic inhibitors of Gram negative multidrug resistance pumps has revealed 
the potential broad spectrum antibacterial activity of rhein, plumbagin, resveratrol, gossypol, 
coumestrol and berberine [64]. 
Other plant products considered as antibiotic potentiators include examples of cell wall acting 
agents and membrane destabilizing agents. A major fraction of essential oils from plant extracts is 
composed of terpenoids which are defined by an isoprene structure of lipophilic nature. Synergy 
between major classes of clinically relevant antibiotics and sesquiterpenoids such as farnesol, nerolidol 
and others has been demonstrated. As opposed to efflux pump inhibition, the mode of action of 
terpenoids may involve, at least in part, bacterial membrane permeabilization as demonstrated by 
studying intracellular accumulation of ethidium bromide using flow cytometry [65] and by measuring Int. J. Mol. Sci. 2009, 10                 
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+ ion leakage [49]. More recently, the sesquiterpene farnesol was shown to drastically increase the 
susceptibility of MRSA toward β-lactams by specifically inhibiting the recycling of the C55 lipid 
carrier needed in bacterial cell wall peptidoglycan biosynthesis [66]. 
The attenuation of virulence as opposed to the direct killing of pathogenic bacteria as a strategy to 
combat infections is an interesting concept. The thought is that antipathogenic molecules that prevent 
for instance the production of toxins or abolish the ability of bacteria to adapt to the mammalian 
environment would give a competitive advantage to the host immune system to allow clearance of the 
infectious organism (Figure 3). It is also anticipated that such virulence attenuators would not affect 
non-pathogenic bacterial communities or exert a selective pressure for the development of resistance 
as seen from the pressures exerted by conventional antibiotics that targeted vital bioprocesses in 
bacteria [67]. One way to interfere with the adaptability of pathogens to the host environment is to 
block quorum sensing systems that usually synchronize the infection process through the production of 
small diffusible signalling molecules that accumulate with increasing bacterial cell density [68,69]. 
Quorum sensing controlled events include the timely induction of a large number of host disabling 
toxins and hydrolytic enzymes. This bacterial strategy prevents the host to gradually detect the 
presence of the invader and to adequately build the immune response. Recently, this concept of 
virulence attenuation was demonstrated by first screening for quorum sensing inhibitory plant extracts 
[70]. This was achieved by the design of reporter genes fused to quorum sensing-controlled promoters. 
In such a screen, a garlic extract, but not synthetic allicin, was determined as one of the most potent 
quorum sensing inhibitors among the samples tested. As such, the garlic extract was further shown to 
reduce  Pseudomonas aeruginosa biofilm tolerance to tobramycin treatment. Furthermore, since 
bacterial biofilm development is an important quorum sensing-mediated process needed for host tissue 
colonization by pathogens such as P. aeruginosa in respiratory infections of cystic fibrosis patients, 
Bjarnsholt et al. [71] tested the prophylactic properties of garlic extracts in a pulmonary mouse model 
of infection. The garlic extract was administered subcutaneously prior to the instillation of the bacteria 
in the lungs and treatment was continued until the mice were sacrificed. Results showed that the garlic 
extract improved clearance of the infecting bacteria and it seemed that not only the garlic extract could 
modulate bacterial quorum sensing events but also, directly or indirectly, adequately modulate the host 
inflammatory response. Since the inflammatory response and the infection profile of a quorum sensing 
mutant is similar to that observed in garlic-treated mice infected with a wild type strain, it is tempting 
to speculate that the improved host response by the garlic extract is directly mediated by the inhibition 
of bacterial quorum sensing systems. This hypothesis is further supported by the observation that 
pseudomonal quorum sensing signalling molecules such as N-acyl homoserine lactones can be 
detected in the sputum of cystic fibrosis patients [72,73] and that such signalling molecules were 
shown to have immunomodulatory activities [74,75]. 
As for the use of efflux pump inhibitors in experimental screens to uncover the true antibacterial 
potential of plant products, new investigational techniques evaluating the specific transcriptional stress 
responses generated by exposure of bacteria to plant products have recently helped identifying 
bioactive plant extracts and the putative mode of action of antibacterial compounds. For example, 
microarray-derived transcriptional analyses confirmed the repression of quorum sensing controlled 
gene expression in P. aeruginosa exposed to garlic extracts [70]. More recently, the transcriptional 
profiles of S. aureus treated with the anthraquinone rhein [76] and the alkaloid berberine [77] were Int. J. Mol. Sci. 2009, 10                 
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disclosed. Results suggest that rhein perturbs S. aureus anaerobic respiration and fermentation [76] and 
further support the expression of efflux pumps in modulating the susceptibility of S. aureus to 
berberine [77]. 
Our own transcriptional analyses of bacteria exposed to plant products have also helped 
understanding their mechanisms of action. For instance, it is well known that the cranberry fruit 
(Vaccinium macrocarpon Ait.) possesses intrinsic antimicrobial properties against many pathogens and 
that some effects may be linked to its bacterial anti-adhesion activity against pathogens [78]. Other 
effects however are possibly due to the various acids and phenolics found in this fruit. The 
mechanisms supporting the diverse effects of cranberry fruit extracts (CFEs) on microbes are poorly 
understood. We thus recently studied the effect of CFEs on E. coli using a DNA array-based approach 
in an attempt to correlate specific transcriptional signatures and bacterial cell damages [79]. Treatment 
of E. coli with CFEs strongly down-regulated OmpF and overexpressed TolQ and Gad, all involved in 
membrane functions, maintenance of ionic balance and protection against high-proton-concentration 
environments [80-82] suggesting important membrane disturbances. The CFEs also strongly down-
regulated the expression of several iron-uptake genes (ent, feo, fep,  exb and others) negatively 
regulated by the transcriptional repressor Fur to limit accumulation of intracellular iron and to prevent 
iron-derived oxidative stresses. Accordingly, extracts were also found to up-regulate genes (ferritin, 
iron superoxide dismutase, fumarase) normally expressed in iron-rich conditions. Such genes are 
known to be negatively regulated by the small RNA ryhB which expression is in turn negatively 
regulated by Fur [83]. In sum, the effects observed on the transcriptome of E. coli exposed to cranberry 
extracts correlated with known characteristics of cranberry constituents such as condensed tannins 
(flavonoids) and phenolics that could possibly act as iron chelators. In view of these results, cranberry 
extracts could potentially lead to the development of agents that perturb bacterial homeostasis. 
Some of our recent works also shed light on the bioactivity of tomatidine, the aglycon version of the 
phytoanticipin tomatine, on S. aureus [84]. Although the minimal inhibitory concentration of the 
compound was high (>128 μg/mL), tomatidine interestingly inhibited hemolysin production by S. 
aureus on blood agar plates. Accordingly, transcriptional analyses of S. aureus exposed to tomatidine 
showed a striking down-regulation of many extracellular toxins, including alpha-hemolysin and delta-
hemolysin (i.e., RNAIII, the effector molecule of the quorum sensing Agr system), serine proteases, 
lipases and nucleases. This modulation of gene expression was seen using tomatidine concentrations as 
low as 1.28 μg/mL and suggests a possible application for tomatidine as a virulence attenuator. 
Furthermore, we are currently also assessing the anti-virulence activity of tomatidine on S. aureus 
small colony variants (SCV) which are slow-growing respiratory deficient derivatives often found in 
the lungs of cystic fibrosis patients [85]. We have previously shown that SCV from cystic fibrosis 
patients have a transcriptional signature of their own that results in expression of virulence factors 
involved in host tissue colonization, cellular invasion and biofilm formation, which are likely to play a 
role in chronic infections [86-88]. We found that biofilm production, which was very elevated in SCV 
compared to prototypical S. aureus strains, was specifically inhibited by tomatidine at subminimal 
inhibitory concentrations [88]. These results indicate that tomatidine has an overall effect on virulence 
determinants in S. aureus and may eventually provide a new avenue for the management of both acute 
and chronic lung infections in cystic fibrosis patients. We have shown here that various types of plant 
products may be used in combination with conventional antibiotics to achieve antibacterial synergy. Int. J. Mol. Sci. 2009, 10                 
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The future of phytoalexins and phytoanticipins as “antibiotic potentiators” or “virulence attenuators” 
for use in human medicine is thus promising. 
 
4. Biotechnological Applications of Phytoanticipins and Phytoalexins in Phytoprotection 
 
The ultimate objective of investigations studying the relevance of phytoanticipins and phytoalexins 
in the plant defence response is to develop biotechnological applications in crop protection. Some of 
the above described phytoalexins provide a potentially interesting weapon to be used in agricultural 
techniques. The use of phytoalexins and phytoanticipins in phytoprotection however entails some 
disadvantages that have to be overcome. 
The use of the phytoalexin itself as a phytoprotectant presumes that the molecule is only toxic 
against pathogenic agents. This is very often not the case and several antimicrobial compounds have 
shown quite unspecific toxicities. Moreover, the synthesis or isolation of phytoalexins is very 
expensive compared to commercial fungicidal molecules [2].    
An alternative approach would be the production of plants that express a higher quantity of 
phytoalexins either by spraying with phytoalexin elicitors, by pre-immunization through a non-
pathogen inoculation, or by genetic transformation. One problem of the first approach is that plants 
continuously elicited to produce phytoalexins results in stunted plants which produce a yield as poor as 
or poorer than the infected plants [2]. Thus, an adequate regulation of the production of phytoalexins 
could help resolving the problem. Indeed, transfer of genes involved in the synthesis of phytoalexins to 
yield more resistant crops has been proven successful in the case of tobacco plants in which 
transformation with stilbene synthase, involved in resveratrol synthesis, provided plant resistance to B. 
cinerea infection [89].  
An additional problem to the use of phytoanticipins and phytoalexins in crop protection is the 
capacity of some pathogens to detoxify phytoalexins into less toxic compounds, or furthermore into 
compounds that can suppress the establishment of a defence response. This activity can be so 
important into the pathogenesis process that it can determine the disease severity of some fungi [90]. 
The discovering and understanding of inhibitors of phytoalexin-detoxifying enzymes is crucial to 
overcome this problem, and it opens a wide variety of biotechnological applications for a new 
generation of chemicals called paldoxins (from phytoalexins detoxification inhibitor) designed to 
provide sustainable treatments of agricultural crops [91]. The use of paldoxin will allow the 
accumulation of the natural defence of the plant in an environmental safer way, since selective 
inhibitors are less likely to affect non-targeted organisms. 
The crucifer phytoalexin brassinin is detoxified by L. maculans and S. sclerotiorum. To date, all the 
potential paldoxins found against S. sclerotiorum seem to be metabolized by the fungus, but results 
seem more promising for L.  maculans. Screening of a potential paldoxin library identified four 
compounds that decreased the rate of brassinin detoxification by L. maculans and these compounds are 
N’-methylbrassinin, naphthyl dithiocarbamate, indolyl dithiocarbonate and phenyl dithiocarbazate.   
N’-methylbrassinin displayed a higher antifugal activity relative to brassinin and thus represents a 
potential paldoxin that could be used in crop protection. Other compounds probed to be better 
inhibitors of fungal growth, but they were also targets of degradation [27]. In a more recent work, new 
paldoxins were designed based on the camalexin scaffold because L. maculans is unable to metabolize Int. J. Mol. Sci. 2009, 10                 
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it [92]. As a result, an even better inhibitor of brassinin oxidase was discovered but unfortunately, this 
compound also induced fungal pathways protecting the microorganism against oxidative stresses and 
brassinin toxicity. Therefore, although paldoxins seem to represent promising chemicals to control 
pathogen infections, a careful analysis of the effect of the molecules in both plant and pathogen 
metabolisms is essential before use of such antimicrobials in crop protection. 
 
5. Conclusions 
 
The numerous examples of plant secondary metabolites (phytoalexins and phytoanticipins) 
reviewed here demonstrate that they constitute an important mechanism to stop spreading of 
phytopathogens in planta, both by acting as antimicrobials themselves or as elicitors of other defence 
responses. More interestingly, some examples described here show that phytoalexins and 
phytoanticipins are also active against clinically-relevant pathogens and their use as “antibiotic 
potentiators” or “virulence attenuators” for the control of infectious diseases in humans is promising. 
The progressing threat of MDR for public health and the incessant need for crop protection strengthen 
the importance of the research activities aiming at the isolation and characterization of plant secondary 
metabolites and the understanding of the mechanisms involved in the natural defences of plants against 
microbial aggressors. 
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